which increased 
alongside the operating income. Other important 
increases can be found in the salaries and 
remuneration which is mainly driven by the index 
adjustment beginning of the year. The R&D expenditure of EUR 55.7 million in 
2023 (EUR 46.7 million in 2022) is capitalized. Development expenditure up to and including 
2022 was capitalized and depreciated over three 
years, while 
research 
expenses 
were 
depreciated immediately in the year of the 
expenditure.